Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Botulinum Neurotoxins Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Botulinum Neurotoxins A (BoNT/A)
  • 1.3.3 Botulinum Neurotoxins B (BoNT/B)
  • 1.3.4 Botulinum Neurotoxins E (BoNT/E)
  • 1.3.5 Botulinum Neurotoxins F (BoNT/F)
  • 1.3.6 Botulinum Neurotoxins C (BoNT/C)
  • 1.3.7 Botulinum Neurotoxins D (BoNT/D)
  • 1.3.8 Botulinum Neurotoxins G (BoNT/G)
• 1.4 Market Segment by Application
  • 1.4.1 Global Botulinum Neurotoxins Market Share by Application (2019-2025)
  • 1.4.2 Medical Uses
  • 1.4.3 Cosmetics
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Botulinum Neurotoxins Market Size
  • 2.1.1 Global Botulinum Neurotoxins Revenue 2014-2025
  • 2.1.2 Global Botulinum Neurotoxins Sales 2014-2025
• 2.2 Botulinum Neurotoxins Growth Rate by Regions
  • 2.2.1 Global Botulinum Neurotoxins Sales by Regions 2014-2019
  • 2.2.2 Global Botulinum Neurotoxins Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Botulinum Neurotoxins Sales by Manufacturers
  • 3.1.1 Botulinum Neurotoxins Sales by Manufacturers 2014-2019
  • 3.1.2 Botulinum Neurotoxins Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Botulinum Neurotoxins Revenue by Manufacturers (2014-2019)
  • 3.2.2 Botulinum Neurotoxins Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Botulinum Neurotoxins Market Concentration Ratio (CR5 and HHI)
• 3.3 Botulinum Neurotoxins Price by Manufacturers
• 3.4 Key Manufacturers Botulinum Neurotoxins Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Botulinum Neurotoxins Market
• 3.6 Key Manufacturers Botulinum Neurotoxins Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Botulinum Neurotoxins A (BoNT/A) Sales and Revenue (2014-2019)
  • 4.1.2 Botulinum Neurotoxins B (BoNT/B) Sales and Revenue (2014-2019)
  • 4.1.3 Botulinum Neurotoxins E (BoNT/E) Sales and Revenue (2014-2019)
  • 4.1.4 Botulinum Neurotoxins F (BoNT/F) Sales and Revenue (2014-2019)
  • 4.1.5 Botulinum Neurotoxins C (BoNT/C) Sales and Revenue (2014-2019)
  • 4.1.6 Botulinum Neurotoxins D (BoNT/D) Sales and Revenue (2014-2019)
  • 4.1.7 Botulinum Neurotoxins G (BoNT/G) Sales and Revenue (2014-2019)
• 4.2 Global Botulinum Neurotoxins Sales Market Share by Type
• 4.3 Global Botulinum Neurotoxins Revenue Market Share by Type
• 4.4 Botulinum Neurotoxins Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Botulinum Neurotoxins Sales by Application

6 United States

• 6.1 United States Botulinum Neurotoxins Breakdown Data by Company
• 6.2 United States Botulinum Neurotoxins Breakdown Data by Type
• 6.3 United States Botulinum Neurotoxins Breakdown Data by Application

7 European Union

• 7.1 European Union Botulinum Neurotoxins Breakdown Data by Company
• 7.2 European Union Botulinum Neurotoxins Breakdown Data by Type
• 7.3 European Union Botulinum Neurotoxins Breakdown Data by Application

8 China

• 8.1 China Botulinum Neurotoxins Breakdown Data by Company
• 8.2 China Botulinum Neurotoxins Breakdown Data by Type
• 8.3 China Botulinum Neurotoxins Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Botulinum Neurotoxins Breakdown Data by Company
• 9.2 Rest of World Botulinum Neurotoxins Breakdown Data by Type
• 9.3 Rest of World Botulinum Neurotoxins Breakdown Data by Application
• 9.4 Rest of World Botulinum Neurotoxins Breakdown Data by Countries
  • 9.4.1 Rest of World Botulinum Neurotoxins Sales by Countries
  • 9.4.2 Rest of World Botulinum Neurotoxins Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Johnson & Johnson
  • 10.1.1 Johnson & Johnson Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Botulinum Neurotoxins
  • 10.1.4 Botulinum Neurotoxins Product Introduction
  • 10.1.5 Johnson & Johnson Recent Development
• 10.2 GSK
  • 10.2.1 GSK Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Botulinum Neurotoxins
  • 10.2.4 Botulinum Neurotoxins Product Introduction
  • 10.2.5 GSK Recent Development
• 10.3 Allergan
  • 10.3.1 Allergan Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Botulinum Neurotoxins
  • 10.3.4 Botulinum Neurotoxins Product Introduction
  • 10.3.5 Allergan Recent Development
• 10.4 Chong Kun Dang
  • 10.4.1 Chong Kun Dang Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Botulinum Neurotoxins
  • 10.4.4 Botulinum Neurotoxins Product Introduction
  • 10.4.5 Chong Kun Dang Recent Development
• 10.5 Eisai
  • 10.5.1 Eisai Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Botulinum Neurotoxins
  • 10.5.4 Botulinum Neurotoxins Product Introduction
  • 10.5.5 Eisai Recent Development
• 10.6 Nestle
  • 10.6.1 Nestle Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Botulinum Neurotoxins
  • 10.6.4 Botulinum Neurotoxins Product Introduction
  • 10.6.5 Nestle Recent Development
• 10.7 Galderma
  • 10.7.1 Galderma Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Botulinum Neurotoxins
  • 10.7.4 Botulinum Neurotoxins Product Introduction
  • 10.7.5 Galderma Recent Development
• 10.8 Ipsen
  • 10.8.1 Ipsen Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Botulinum Neurotoxins
  • 10.8.4 Botulinum Neurotoxins Product Introduction
  • 10.8.5 Ipsen Recent Development
• 10.9 Hugel
  • 10.9.1 Hugel Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Botulinum Neurotoxins
  • 10.9.4 Botulinum Neurotoxins Product Introduction
  • 10.9.5 Hugel Recent Development
• 10.10 Mentor
  • 10.10.1 Mentor Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Botulinum Neurotoxins
  • 10.10.4 Botulinum Neurotoxins Product Introduction
  • 10.10.5 Mentor Recent Development
• 10.11 CROMA
• 10.12 Alphaeon
• 10.13 OBI Pharma
• 10.14 Revance Therapeutics
• 10.15 Daewoong Pharmaceutical
• 10.16 Medy-Tox
• 10.17 EpiVax
• 10.18 Anterios
• 10.19 Escape Therapeutics
• 10.20 Lipella
• 10.21 Malvern Cosmeceutics
• 10.22 PharmaVital
• 10.23 Merz Pharma
• 10.24 Transdermal
• 10.25 Valeant Pharmaceuticals
• 10.26 CNBG

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Botulinum Neurotoxins Sales Channels
  • 11.2.2 Botulinum Neurotoxins Distributors
• 11.3 Botulinum Neurotoxins Customers

12 Market Forecast

• 12.1 Global Botulinum Neurotoxins Sales and Revenue Forecast 2019-2025
• 12.2 Global Botulinum Neurotoxins Sales Forecast by Type
• 12.3 Global Botulinum Neurotoxins Sales Forecast by Application
• 12.4 Botulinum Neurotoxins Forecast by Regions
  • 12.4.1 Global Botulinum Neurotoxins Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Botulinum Neurotoxins Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Botulinum Neurotoxins is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Botulinum Neurotoxins.

This report studies the global market size of Botulinum Neurotoxins, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Botulinum Neurotoxins sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Johnson & Johnson
GSK
Allergan
Chong Kun Dang
Eisai
Nestle
Galderma
Ipsen
Hugel
Mentor
CROMA
Alphaeon
OBI Pharma
Revance Therapeutics
Daewoong Pharmaceutical
Medy-Tox
EpiVax
Anterios
Escape Therapeutics
Lipella
Malvern Cosmeceutics
PharmaVital
Merz Pharma
Transdermal
Valeant Pharmaceuticals
CNBG

Market Segment by Product Type
Botulinum Neurotoxins A (BoNT/A)
Botulinum Neurotoxins B (BoNT/B)
Botulinum Neurotoxins E (BoNT/E)
Botulinum Neurotoxins F (BoNT/F)
Botulinum Neurotoxins C (BoNT/C)
Botulinum Neurotoxins D (BoNT/D)
Botulinum Neurotoxins G (BoNT/G)

Market Segment by Application
Medical Uses
Cosmetics

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Botulinum Neurotoxins status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Botulinum Neurotoxins manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Botulinum Neurotoxins are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025